Comparison

Entecavir European Partner

Item no. TMO-T0085L-200mg
Manufacturer TargetMol
CASRN 142217-69-4
Amount 200mg
Category
Type Inhibitor
Specific against other
Purity 0,9972
Smiles Nc1nc2n(cnc2c(=O)[nH]1)[C@H]1C[C@H](O)[C@@H](CO)C1=C
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias HBV, SQ34676 , BMS200475
Available
Short Description
Entecavir is a guanosine nucleoside analogue used in the treatment of chronic hepatitis B virus (HBV) infection. Entecavir therapy can be associated with flares of the underlying hepatitis B during or after therapy, but has not been linked to cases of clinically apparent liver injury.
Shipping
cool pack
Storage
-20°
Target names or alias
SQ34676 , BMS200475
Molecular Weight
277, 28
Pathway
Microbiology/Virology
Target
HBV

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close